CYB-004 (Cybin)

N/A

Report date: 2025/02/28 11:25:09
NME

Base Information

Drug NameCYB-004 (Cybin)
Drug Alias Namedeuterated dimethyltryptamine (Cybin)
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Deuterated drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor modulatorsSerotonin 2a (5-HT2a) receptor modulators
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsAnxiety Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCybin Inc
China Registration ClassN/A

Develop Information

Active CompaniesCybin Inc
Inactive CompaniesN/A
Active IndicationsAnxiety Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A